Department of Immunology, Theodor Bilharz Research Institute (TBRI), Giza, Egypt.
Physiology Departement, Egyptian Drug Organization, Giza, Egypt.
Dig Dis. 2021;39(5):534-539. doi: 10.1159/000514356. Epub 2021 Jan 13.
Malignant ascites results from imbalance between protein in the peritoneal cavity and absorption of fluids via the lymphatic system. More than 20 interleukins (ILs) are known to play an important role in the protection against tumors.
Ascitic fluid IL-1B, IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ levels were assessed in 45 patients with liver cirrhosis and ascites as judged by histopathological and ultrasonographic findings. They were divided into 2 groups according to presence of hepatic focal lesions. Ten patients with focal hepatic lesions were randomly selected and subjected to analysis of serum levels of IL-2 and IL-10.
Ascitic fluid IL-4, IL-6 and IL-10 levels were found to be significantly higher in patients with hepatocellular carcinoma (HCC) than patients with cirrhosis. TNF-α, and IFN-γ were also found to be higher in HCC than patients with cirrhosis but with no significance. On the other hand, there was no significant difference in levels of IL-1B and IL-2 between the 2 groups. Ascitic fluid IL-2 and IL-10 levels were found to be higher in ascitic fluid than in serum of the same patients.
Ascitic fluid levels of IL-4, IL-6 and IL-10 are higher in HCC patients than patients with cirrhosis alone. Levels of ascitic fluid IL-2 and IL-10 proved to be a better prognostic tool than their levels in sera of the same patients. To conclude, patients with cirrhosis may be subjected to scheduled examination of ascitic fluid cytokines to predict transformation into HCC.
恶性腹水是由于腹腔内蛋白质与淋巴系统吸收液体之间的失衡导致的。有 20 多种白细胞介素(IL)被认为在抗肿瘤保护中发挥重要作用。
根据组织病理学和超声检查结果,评估了 45 例肝硬化和腹水患者的腹水白细胞介素-1β(IL-1β)、白细胞介素-2(IL-2)、白细胞介素-4(IL-4)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)和干扰素-γ(IFN-γ)水平。根据是否存在肝局灶性病变,将患者分为 2 组。随机选择 10 例有肝局灶性病变的患者进行血清 IL-2 和 IL-10 分析。
与肝硬化患者相比,肝细胞癌(HCC)患者的腹水白细胞介素-4(IL-4)、白细胞介素-6(IL-6)和白细胞介素-10(IL-10)水平明显升高。TNF-α和 IFN-γ在 HCC 患者中也高于肝硬化患者,但无统计学意义。另一方面,两组患者的腹水白细胞介素-1β(IL-1β)和白细胞介素-2(IL-2)水平无显著差异。与同组患者的血清相比,腹水 IL-2 和 IL-10 水平更高。
与单纯肝硬化患者相比,HCC 患者腹水白细胞介素-4(IL-4)、白细胞介素-6(IL-6)和白细胞介素-10(IL-10)水平升高。腹水白细胞介素-2(IL-2)和白细胞介素-10(IL-10)水平较同组患者血清水平更能作为预后工具。总之,对于肝硬化患者,可进行腹水细胞因子的定期检查,以预测其向 HCC 的转化。